ÂÜÀòÂÒÂ×

Robin Eryan holds a Master's Degree in Biology from Seton Hall University and an MBA in Marketing and International Business from Rutgers Graduate School of Management. Currently serving as a Senior Clinical Scientist at Valerio Therapeutics since June 2023, Robin previously worked in various roles in the clinical research field at companies like FSP dedicated to Merck Oncology Early Development, Moffitt Cancer Institute, and Octapharma USA, Inc. With a wealth of experience across different sectors, Robin's expertise in clinical research and monitoring is highly valued in the industry.